sch 28080 has been researched along with vonoprazan in 3 studies
Studies (sch 28080) | Trials (sch 28080) | Recent Studies (post-2010) (sch 28080) | Studies (vonoprazan) | Trials (vonoprazan) | Recent Studies (post-2010) (vonoprazan) |
---|---|---|---|---|---|
217 | 0 | 20 | 299 | 78 | 295 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Gerle, C; Hayashida, K; Khandelia, H; Madapally, HV; Morita, M; Oshima, A; Shigematsu, H; Tanaka, S; Yamagishi, T | 1 |
Arikawa, Y; Hirase, K; Hori, Y; Imanishi, A; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Tsukimi, Y | 1 |
Abe, K; Fujiyoshi, Y; Irie, K; Nakanishi, H; Suzuki, H | 1 |
3 other study(ies) available for sch 28080 and vonoprazan
Article | Year |
---|---|
Structural Basis for Binding of Potassium-Competitive Acid Blockers to the Gastric Proton Pump.
Topics: Gastric Acid; Potassium; Proton Pump Inhibitors; Proton Pumps; Stomach | 2022 |
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Dithiothreitol; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Kinetics; Lansoprazole; Ligation; Male; Potassium; Proton Pump Inhibitors; Pylorus; Pyrroles; Rats; Rats, Sprague-Dawley; Stomach; Sulfonamides; Swine | 2010 |
Crystal structures of the gastric proton pump.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cations, Monovalent; Crystallography, X-Ray; H(+)-K(+)-Exchanging ATPase; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Imidazoles; Models, Molecular; Potassium; Protein Binding; Proton Pump Inhibitors; Protons; Pyrroles; Rabbits; Stomach; Sulfonamides; Swine | 2018 |